Jinling Pharmaceutical Co (SZSE:000919) 3-Year EBITDA Growth Rate : 0.60% (As of Mar. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Jinling Pharmaceutical Co 3-Year EBITDA Growth Rate?

Jinling Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.12.

During the past 12 months, Jinling Pharmaceutical Co's average EBITDA Per Share Growth Rate was -8.80% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 0.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -11.30% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -4.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Jinling Pharmaceutical Co was 47.80% per year. The lowest was -13.10% per year. And the median was 4.10% per year.

Competitive Comparison of Jinling Pharmaceutical Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Jinling Pharmaceutical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jinling Pharmaceutical Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jinling Pharmaceutical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Jinling Pharmaceutical Co's 3-Year EBITDA Growth Rate falls into.

Jinling Pharmaceutical Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Jinling Pharmaceutical Co (SZSE:000919) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Jinling Pharmaceutical Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Jinling Pharmaceutical Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Jinling Pharmaceutical Co (SZSE:000919) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jinling Pharmaceutical Co Ltd (SZSE:000919) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

No. 238 Zhongyang Road, Jinling Pharmaceutical Building, Nanjing, Jiangsu, CHN, 210009

Website

http://www.jlyy000919.com

Jinling Pharmaceutical Co Ltd is a China-based pharmaceutical company.

Executives

Fan Jin Tian	Director
Jia Ming Yi	Executives
Li Quan	Executives
Chen Sheng	Executives
Xu Jun Yang	Secretary Dong
Wang Yang	Executives
Yin Jian Biao	Executives
Li Jian	Executives
Liang Yu Tang	Directors, executives
Zhang Ning	Executives
Li Chun Min	Director
Sui Li Cheng	Executives
Tang Wei Guo	Directors, executives
Wang Suo Jin	Executives
Shen Zhi Long	Director

Jinling Pharmaceutical Co (SZSE:000919) Headlines

No Headlines